Canadian marijuana giant Aurora Cannabis has filed an application to list its shares on the New York Stock Exchange, a move that would make it the second major plant-touching company to trade on the Big Board – and the latest from Canada to establish roots on Wall Street. If approved, the Edmonton-based company could begin […]
Read MoreCronos Group
Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids
Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer a wide range of cannabinoids found in cannabis.
Read More
Analyst says Cronos stock swings ‘overdone,’ calls deception allegations ‘unfounded’
Shares of Cronos Group were punished by investors this week after the Ontario-based licensed producer of cannabis was targeted by short-seller Andrew Left of Citron Research – but at least one analyst called the wild swing “overdone.” Citron’s report, issued Aug. 30, accused the Cronos management team of “deceiving the investing public” by not disclosing the […]
Read More
Germany turns to Netherlands for more medical marijuana
The Netherlands has agreed to significantly increase shipments of medical cannabis to Germany to help the country cope with soaring demand.
Read More
Australia sees significant increase in medical cannabis patient count
The streamlined processes for medical marijuana applications in Australia’s most populous state is starting to produce positive results, although patient access remains “appalling” across the country, according to at least one elected official.
Data shared with Marijuana Business Daily by the New South Wales health regulator shows that 322 applications for medical marijuana have been approved since the state made it easier for doctors to prescribe cannabis in March.
Oregon marijuana firm Cura expands into Canada, eyes overseas growth
One of the biggest cannabis companies in the U.S. by revenue announced a partnership and supply deal with one of Canada’s top licensed producers.
Read More
Ontario’s cannabis pivot could create massive retail opportunities
A week after it was reported that Ontario froze leasing efforts for its monopoly cannabis retail chain, Canada’s largest province appears to be on the verge of handing adult-use marijuana sales entirely to the private sector. The news, first reported by Cannabis Compliance Vice President Deepak Anand and then in The Globe and Mail, would reverse the […]
Read More
‘Blistering’ growth in German medical cannabis market
Data from the Federal Institute for Drugs and Medical Devices (BfArM) in Germany provides a rare snapshot of the quantity of medical cannabis needed to meet demand in the world’s largest federally regulated MMJ market.
Read More
Former aide to Ontario premier: Decision ‘within weeks’ on cannabis retail
A key member of Ontario Premier Doug Ford’s inner circle thinks the new premier could make a decision cannabis sales in Canada’s largest market within weeks.
Read More
Canada recreational cannabis sales to begin in October after historic vote
Canada ended 95 years of cannabis prohibition Tuesday, passing landmark legislation – Bill C-45 – that lays the groundwork for a multibillion-dollar marijuana industry.
Read More
Time is right for marijuana entrepreneurs to enter the global market
North American marijuana entrepreneurs who believe it’s too early to look at international opportunities should reconsider their position.
Read More
Canopy Growth becomes first plant-touching cannabis company on NYSE; shares fall
The New York Stock Exchange listed its first cannabis cultivator today, marking a key milestone that analysts say makes the industry more accessible to institutional and retail investors – and could draw large American banks to the sector. In its debut, Canopy Growth ended the day down 6.66%, closing at $28.20.
Read MoreJanuary Issue
